本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Invivyd, Inc.

0.7200
-0.0858-10.65%
盤後0.74300.0230+3.19%17:40 EDT
成交量:126.10萬
成交額:94.41萬
市值:8,612.35萬
市盈率:-0.37
高:0.8300
開:0.8200
低:0.7200
收:0.8058
資料載入中...

公司資料

公司名字:
Invivyd, Inc.
交易所:
NASDAQ
成立時間:
2020
員工人數:
95
公司地址:
1601 Trapelo Road,Suite 178,Waltham,Massachusetts,United States
郵編:
02451
電話:
傳真:
- -
簡介:
Invivyd, Inc.於2020年6月3日在特拉華州成立。該公司是一家處於商業階段的公司,其使命是快速、永久地提供基於抗體的療法,以保護脆弱人群免受流行病毒威脅的破壞性後果,從SARS-CoV-2開始。該公司專有的INVYMAB平台方法將最先進的病毒監測和預測建模與先進的抗體工程相結合。INVYMAB旨在促進快速、連續產生新的單克隆抗體(“MAB”),以跟上不斷演變的病毒威脅。

董事

名稱
職位
Tillman U. Gerngross
Co-Founder, Chief Executive Officer and Director
Rene Russo
Co-Founder, Director and Chair of the Board
Ajay Royan
Director
Anand Shah
Director
Howard Mayer
Director
Michael Wyzga
Director
Terrance McGuire
Director
Tom Heyman
Director

股東

名稱
職位
Tillman U. Gerngross
Co-Founder, Chief Executive Officer and Director
David Hering
Chief Operating Officer
Jane P. Henderson
Chief Financial Officer
Elham. Hershberger
Chief Development Officer
Lynn Connolly
Chief Medical Officer
Rebecca Dabora
Chief Technology & Manufacturing Officer
Rene Russo
Co-Founder, Director and Chair of the Board